We analyzed the molecular mechanism for the immunoglobulin (Ig) multiple isotype expression using a transgenic mouse (TG .SA) model system . Though most of the endogenous p, chain expression was excluded by the expression of the human rearranged A transgene in the TG.SA mouse, a significant portion of splenic B lymphocytes could express the transgenic human IgM and endogenous mouse IgG simultaneously after stimulation with lipopolysaccharide and interleukin 4. The fluorescence-activated cell sorter®-purified population of the human IgM+/mouse IgG cells expressed mRNA that consisted of properly spliced sequences of the transgenic VDJ and the endogenous mouse Cy genes (trans-mRNA), together with the transgenic human p, mRNA and germline transcripts of the mouse Cy gene, without apparent rearrangement of the transgene. We also found that a lymphoma tumor, derived from the cross between the TG.SA mouse and another transgenic mouse carrying Ig H chain enhancer-driven c-myc oncogene, expressed about equal levels of the trans-mRNA and the transgenic p, mRNA without DNA rearrangement in either the transgene or the endogenous mouse switch region . These findings strongly support our previous proposal that the trans-splicing can account for the multiple isotype expression in this transgenic model and also suggest that novel molecular mechanism(s) might be involved in this reaction.
Summary
We analyzed the molecular mechanism for the immunoglobulin (Ig) multiple isotype expression using a transgenic mouse (TG .SA) model system . Though most of the endogenous p, chain expression was excluded by the expression of the human rearranged A transgene in the TG.SA mouse, a significant portion of splenic B lymphocytes could express the transgenic human IgM and endogenous mouse IgG simultaneously after stimulation with lipopolysaccharide and interleukin 4. The fluorescence-activated cell sorter®-purified population of the human IgM+/mouse IgG cells expressed mRNA that consisted of properly spliced sequences of the transgenic VDJ and the endogenous mouse Cy genes (trans-mRNA), together with the transgenic human p, mRNA and germline transcripts of the mouse Cy gene, without apparent rearrangement of the transgene. We also found that a lymphoma tumor, derived from the cross between the TG.SA mouse and another transgenic mouse carrying Ig H chain enhancer-driven c-myc oncogene, expressed about equal levels of the trans-mRNA and the transgenic p, mRNA without DNA rearrangement in either the transgene or the endogenous mouse switch region . These findings strongly support our previous proposal that the trans-splicing can account for the multiple isotype expression in this transgenic model and also suggest that novel molecular mechanism(s) might be involved in this reaction. P rogeny of a single B lymphocyte can switch the isotype of the expressed Ig from IgM to IgG or other classes without changing the variable region sequence that determines the antigen specificity (1, 2) . This phenomenon, named Ig class switching, is mediated by DNA rearrangement of the constant region (C) genes of the Ig heavy chain . This DNA rearrangement, called S-S recombination, takes place between the S regions located 5' to each C gene, except for the Cs gene, and brings the VDJ exon to proximity of the C gene to be expressed by the deletion of the intervening CH gene(s). Recent investigations have shown that the C gene(s) to be deleted by S-S recombination is excised out from the chromosome as a circular DNA (3) (4) (5) . This finding provides the direct evidence for the intrachromosomal, looping-out deletion model for S-S recombination (6) . These studies also indicate that 114 can modify the specificity of the recombination target gene (4, 5) .
Although deletion of the C genes by S-S recombination occurs in myelomas (7, 8) , hybridomas (9) , and normal spleen cells (10) , the deletion model has faced difficulty in explaining the observation that a single B lymphocyte can express more than one isotype simultaneously on the surface (11) . From the experiments showing that sorted B cells (12, 13) or B cell tumors (14, 15) carrying two isotypes had no rearrangement of the expressed C genes, the involvement of RNA processing in multiple isotype expression was suggested, and such multiple isotype-expressing cells were proposed to be intermediates for class switching (2, 12) . The production of multiple isotypes in a single B cell could be accomplished by either differential splicing of one continuous transcript of 200 kb or by intermolecular joining of two shorter transcripts (trans-splicing) . Given the fact that specific germline transcripts were made from the target C gene(s) of S-S recombination (16-18), we proposed that such transcripts could be involved in the Ig multiple isotype expression as substrates (acceptors) for trans-splicing (19-21) .
We have tested the trans-splicing model using a human p, chain transgenic mouse line (TG.SA) as a model system (20, 21) . Despite the integration of the transgene outside of the mouse H chain loci, splenic B cells from TG.SA mice could synthesize a trans-mRNA that was generated by splicing the transgenic human VDJ exon sequence properly to the C, exon sequence of the endogenous mouse C7t gene . This trans-mRNA synthesis could be due to either S-S recombination between the transgene and the endogenous C y1 gene or trans-splicing between their transcripts, but could not be accomplished by differential splicing of one contiguous transcript (20, 21) .
To exclude that trans-mRNA was produced by interchromosomal S-S recombination, we have tested whether S-S recombination took place in the sorted B cells expressing transgenic human IgM and endogenous mouse IgG and a TG.SA derived lymphoma tumor expressing the trans-mRNA. We found that these cells are expressing trans-mRNA without DNA rearrangement . Our data strongly suggest that the transmRNA is synthesized by the trans-splicing mechanism and that this mechanism may be involved in multiple isotype expression in B cells.
Materials and Methods
Transgenic Mouseand CellsDerivedfrom it. The transgenic mouse line (TG.SA) carries a rearranged human VDJ-C gene that allows expression of the membrane-bound A. chain alone (22) . Pre-(no. 210) and pro-(no. 216) B cell lymphomas arose spontaneously by crossing the TG.SA line with another transgenic mouse carrying the Ig H chain enhancer-driven c-myc oncogene (23) . The transgenic human W mRNA was expressed in both tumors but the trans-mRNA was expressed in only no. 216 tumor. Hybridoma 2D9, which expressed endogenous mouse y2 transcript, was made by fusion between the spleen cell from TG .SA and the Ig-nonproducing myeloma NSl. TG.SA animals were maintained by crossing with FVB/N mice (Taconic Farms, Germantown, NY), or with C57BL/6 mice (SIC, Hamamatsu, Japan) . The first generation of the animals crossed with C57BL/6 mouse were used for the sorting experiments .
Spleen Cell Culture Flow Cytometry, andSorting. Spleen cells from the TG.SA line were prepared and cultured 3 d in 5% C02-95% air at 37°C as described previously (20, 21) . Fluorescence staining of surface Igs (20, 21) and brief acid treatment that dissociates Igs associated through Fc receptors (24, 25) were done as described. Stained cells were analyzed by flow cytometry on FACScana and FACStar®, and human IgM* /mouse IgG* cells were sorted using FACStar® by a Consort 30 program (Becton Dickinson & Co ., Mountain View, CA). FITC-labeled anti-human u chain antibody and R-PE-labeled anti-mouse y chain antibody of goat were obtained from Southern Biotechnologies (Birmingham, AL) .
I-blymerase Chain Reaction . Cytoplasmic RNA from the sorted cells was extracted using ribonucleoside-vanadyl complex (New England Bio Labs, Beverly, MA) as an RNase inhibitor (26) , andDNA from the same cells was extracted from the nuclear pellet at the same time . Total cellular RNAs from tumors and hybridomas were extracted by the guanidium isothiocyanate method (27) . mRNAs were converted to cDNAs using oligo(dT),2-,s primer and AMV reverse transcriptase (Seikagaku Kogyo, Tokyo, Japan; and Boehringer Mannheim Biochemicals, Indianapolis, IN) (20, 21) . Kits for cDNA synthesis were purchased from Boehringer Mannheim Biochemicals and Amersham Japan (Tokyo, Japan). PCR was performed as described (20, 21, 28) using synthesized oligonucleotides as primers. Amplification was done by 50 cycles using an automated DNA thermal cycler and Taq DNA polymerase (AmpliTaq; Perkin-Elmer/Cetus, Norwalk, CT). Primers for PCR were synthesized using automated DNA synthesizers (models 380A, B and
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Immunoglobulin Multiple Isotype Expression by Trans-Splicing 381A; Applied Biosystems, Inc., Foster City, CA). Positions of primers were as follows. Transgenic human V primer 1 (abbreviated as tV in figures), 24 met from 356 bases upstream to the end of the J6 in the V sequence, sense strand (20, 21, 29) ; transgenic human V primer 2 (tV2), 21 met from 332 bases upstream to the end of the J6 in the V sequence, sense strand (20, 21, 29) ; human C,, primer (hW), 31 met from position 31 to 1 of the C, exon, antisense strand (30) ; mouse C,., primer 1 (my), 21 met from position 41 to 21 of the C, exon, antisense strand (30); mouse C,., primer 2 (myl-2, 21 mer from position 251 to 231 of the C, exon, antisense strand (30) ; mouse I,., primer (mlyl), 21 met from 186 base upstream of the end of the I,., exon (31) ; human c-myc exon 1 primer (ml), 21 met from 412 bases upstream of the end of the 1st exon of the human c-myc gene, sense strand (32) ; human c-myc exon 2 primer (m2), 21 met from 55 bases downstream of the beginning of the second exon of the human c-myc gene, antisense strand (32) . Analyses of amplified fragments by agarose gel electrophoresis and nucleotide sequencing by dideoxy chain termination method (33) were done as described before (20, 21) .
Other Molecular Biological Analyses. Southern blot hybridization was done as described (34) using probes that were labeled with 12p by random hexamer priming method (35) . Filters were washed at 65°C in 0.3x SSC-0.1% SDS in Fig. 2 ), the 10-kb EcoRI-HindIII fragment of mouse S,., region (38, 39) , and the 6.6-kb EcoRI fragment of mouse S.yz region crosshybridizing with S,.2, region under stringent washing condition (39, 40) were used as probes to detect switch recombination. The 0.5-kb HindIII-BamHI fragment of Evi-2 (41; unique copy) and the 0.6-kb promoter region fragment upstream to the BamHI site of the ribosomal RNA gene (42; .multiple copy) were used for calibration of DNA amounts. Autoradiograms of DNA blots from the sorted samples were taken and analyzed using a Bio-image analyzer (BAS2000 ; Fuji Film, Tokyo, Japan) . RNase protection assay was carried out as described previously (43) . Hybrids were digested with mixture of RNases A (0 .1 mg/ml), TI (100 U/ml), and T2 (10 U/ml) at 37°C for 40 min, and then run on 6% polyacrylamide gel containing 7 M urea . a-["P]-Labeled UTP and dCTP were purchased from New England Nuclear (Boston, MA) and Amersham Japan (Tokyo, Japan) . Restriction endonucleases, T7 RNA polymerase, and Klenow fragment of DNA polymerase I were purchased from Takara (Kyoto, Japan) and New England Bio Labs, and used according to their instructions .
Results
Purification of Human IgM+/Mouse IgG+ Cells from Stimulated Spleen Cells of. the Transgenic Mouse TG.SA . As we reported previously (20, 21) , a significant portion (3-8%) of the spleen cells from the TG.SA transgenic mouse expressed transgenic human IgM and the endogenous mouse IgG simultaneously on their surface after a 3-4 d culture with LPS and ILA ( Fig. 1 A) , although expression of the endogenous mouse P chain was almost completely excluded (20) (21) (22) . To exclude the possibility that these Ig molecules on the cell surface were synthesized by some other cells, and cytophilically associated through Fc receptors, the cells were treated briefly with acid to dissociate the interactions between Igs and Fc receptors. The staining profile of acid-treated cells was almost identical to that of untreated cells (Fig. 1 C) The purity of the sorted cells was >90% as assessed by observation under a fluorescence microscope (92 of 100 cells observed were positive for both isotypes) and re-analysis using FAGS® (Fig. 1 B) . IgM+/mouse IgG+ cells, we took the PCR strategy as schematically illustrated in Fig. 2 . By each combination of the primers indicated, we detected a clear band of the expected size for the transgenic human p. mRNA, the trans-mRNA, and the germline Cy1 transcript (Fig. 3) . From semiquantitative experiments by decreasing the amount of cDNA subjected to PCR, we could estimate that each human IgM+/ mouse IgG+ cell contains >100 and >10 molecules on average of the transgene mRNA and the trans-mRNA, respectively (data not shown) . These results strongly support the fact that the human k, chain and the chimeric y chain were synthesized de novo by the human IgM+/mouse IgG+ cells. The TG.SA mice carried two copies of the rearranged human W chain gene as the transgene at a single locus on a chromosome different from number 12 where the endogenous Ig H chain locus is located . To test whether the trans-mRNA was produced by interchromosomal S-S recombination be- tween the transgene and the endogenous C.y gene, we analyzed the transgene configuration in the sorted human IgM+/mouse IgG* cell population by Southern blot hybridization . At first a careful estimation of the relative amount of DNA from the sorted cells against the germline control DNA (liver or tail) was done either by ethidium bromide staining (Fig. 4 A) or by hybridization of the same filter with unrelated probes (Fig. 4 B) . Ifthe majority of the sorted cells underwent S-S recombination in one of the two copies of the transgene, the intensity of the transgene band in the doublepositive cells should decrease to about halfof that of the germline control, and the rearranged bands should migrate as a smear because of the heterogeneity of switch recombination sites. The relative intensities of the fragments (9.0-kb Hin- Lymphoma from the 'IG.SA Line Expressed the traps-mRNA without S-S Recombination. To overcome the limitations of the above experiments, we looked for TG.SA-derived monoclonal B cell lines and tumors that express the traps-mRNA . The probe used for RNase protection assay should give rise to a 397-base protected band for the traps-mRNA between transgenic human V.DJ. and endogenous mouse Cy (Cyt, Cy26, and Cy&) genes, and a 356-base band for transgene products, because these C., genes have only a few discontinuous point mutations in the 5' 41 bases (Fig. 5 A, left) . 12 lymphomas derived from transgenic crosses between a lymphoma prone strain and a human IgM-carrying strain were screened (23) . One, no. 216, a solitary pro-B cell lymphoma, that was negative for surface IgM but positive for the Ly5/B220 antigen and had no Ig gene rearrangements contained almost equal amounts of the traps-mRNA and transgene mRNA even under a stringent condition for the RNase treatment (Fig. 5 A) . Under this RNase treatment condition using RNases A, Tl, and T2, no artificially protected bands were observed in a mixture of human w and mouse y transcripts (Fig. 5 A) .
To confirm that the 397-base protected product is due to the properly spliced traps-mRNA, we carried out the PCR experiment using the same primer combination as in our previous report (20, 21) . The 3' primer for the traps-mRNA Figure 4 . Absence of interchromosomal switch recombination in the sorted double bearers. Indicated amounts of DNA from the sorted cells and liver DNA from the same line (A) or tail DNA from the same animal (B) were digested with HindIII (A) or EcoRI plus BamHI (B) and subjected to electrophoresis in 0 .6% agarose gel and transferred on to nylon (A) or nitrocellulose (B) filters. The filters were hybridized with human it chain cDNA (probe c in Fig. 2) in A, or a mixture of the human enhancer fragment 1 (probe a in Fig. 2 ) and Evi-2 fragment in B. The filter used in B was rehybridized with ribosomal RNA gene probe to confirm the DNA amount, and the result is shown below B . Sizes of the detected bands are shown by arrows .
Shimizu et al . detection could amplify Cyt, Cy2b, and Cy2, mRNAs because it was complementary to the mouse Cyi sequence with only one base difference from the Cy2b and Cy 2, sequences. DNA fragments of expected sizes for the transgenic mRNA and the trans-mRNA were amplified from tumor no. 216 cDNA (Fig. 5 B) . Specificity of the primers was confirmed by amplification of previously cloned cDNAs of transgenic it mRNA and trans-mRNA . The transgenic V primer and mouse Cy primer combination gave no band from transgene cDNA clone (Fig . 5 B) . Since no amplified bands were de- tected by combination of transgenic V and c-myc oncogene primers, or c-myc oncogene and transgenic CN primers, in spite of the presence of abundant c-myc mRNA in this tumor, combination of the exon sequences spliced in trans-mRNA was specific. Amplified cDNA of the trans-mRNA from tumor no. 216 was subcloned and sequenced . As shown in Fig. 5 C, the transgenic VDJ exon sequence was properly spliced to the first exon sequence of the mouse Cy2 a gene. This sequence data unequivocally demonstrate that the tumor no. 216 expressed the properly spliced trans-mRNA ofthe transgenic VHDJH and endogenous mouse Cy2, regions, and also exclude the contamination of previously cloned cDNA (V. Cyl) because we have never constructed artificial trans-mRNA or cDNA of the y2a isotype.
Monoclonal DNA rearrangement in the no. 216 lymphoma should be easily detected. We have analyzed rearrangement of the endogenous S regions for the Cyl, Cy2b, and Cy2a genes and the transgene by Southern blot hybridization using mouse Sy1 (Fig. 6 A) , Sy2b (crosshybridized with Sy2a) (Fig.  6 B) , and human Ig H chain enhancer regions (Fig. 6 , C and D) as probes . None of these probes detected monoclonal rearrangement of the transgene and the Cy genes. The relative band intensities of these genes remained unchanged, excluding polyclonal rearrangement as well. These results strongly suggest that no. 216 tumor cells expressed the transmRNA without S-S recombination and support the fact that trans-splicing is a likely mechanism for generation of trans-mRNA .
Discussion
We have shown that the trans-mRNA containing the transgenic human V region and the endogenous Cy sequences are expressed in lymphoma cells as well as double-positive sorted spleen cells derived from the TG.SA transgenic mice. These cells did not show any sign of S-S recombination . The results support the hypothesis that trans-splicing is responsible for generation of trans-mRNA . Synthesis of trans-mRNA does not seem to be dependent on either the specific insertion site of the transgene or the specific V or C region sequence of the transgene, because we could detect trans-mRNA in similarly stimulated spleen cells of another transgenic mouse line that carried a rearranged mouse VDJCp gene (H. Han, A. Shimizu, and T Honjo, unpublished results). We could not exclude a formal possibility that S-S rearrangement took place in a small portion of the sorted and tumor cells, and all the trans-mRNAs were produced by that portion of cells . However, this possibility seems very unlikely because most of the sorted cells carried human IgM and mouse IgG simultaneously on their surface and expressed the trans-mRNA together with transgenic human tt mRNA and sterile Cy1 transcripts, and the expression level of trans-mRNA in the lymphoma tumor was almost equal to that of the transgene transcript.
Obviously, our results do not exclude interchromosomal S-S recombination per se. In fact, other investigators suggested S-S recombination between transgenic p. and endoge-139 0
Immunoglobulin Multiple Isotype Expression by Trans-Splicing nous y genes (44, 45) . However, their cases differ from ours in that their transgenic mice contain a high-copy number of the murine it gene as the transgene, and trans-expression was induced by specific antigen (arsenate) stimulation (44, 45) . Because of the extensive homology between the endogenous loci and high-copy transgene, homologous recombination rather than S-S recombination might occur and a rare recombinational product could have been selected by antigen stimulation and during the hybridoma selection . The TG.SA transgene is shown to be integrated outside of the endogenous Ig H chain loci by breeding experiments (21) . We have confirmed this by analyzing a hybridoma (2D9) that lacks the transgene but still retains the endogenous H chain locus of the TG.SA mouse (Fig. 6 ) . Discontinuous synthesis of mRNA is a feature ofmRNA metabolism in several lower organisms (46) , but has not been demonstrated in intact higher eukaryotic cells. The two wellcharacterized modes of discontinuous transcription are RNAmediated priming or cap transfer (46) and trans-splicing (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) . The former is known to occur in several viral systems, but this mechanism is probably not involved in the Ig transmRNA synthesis because joining at a splicing site like transmRNA does not occur by this mechanism and the transgenic human sequence has only partial homology with its murine counter part. On the other hand, trans-splicing was demonstrated in several lower eukaryotes (46) (47) (48) (49) (50) (51) , plant chloroplasts (52-54), and nuclear extracts of HeLa cell (55, 56) . Although trans-splicing is a most likely and reasonable mechanism to generate the trans-mRNA, the following three unique features of the splicing donor make the present Ig trans-mRNA synthesis unprecedented. First, only specific pairs of transcripts are trans-spliced. No other trans-splicing systems require a specific splicing donor except for the self-catalyzed type in chloroplasts (57) . Second, the Ig, the donor sequence of the trans-splicing, has a intron to be cis-spliced as the V region gene is composed of two exons . Third, the donor is part of intact transcription unit and thus processed by both cis-(for the p, mRNA) and trans-(for the second isotype mRNA) splicing. Therefore, novel molecular mechanism(s) should be involved in the Ig trans-mRNA synthesis by trans-splicing to determine the joining specificity of donor and acceptor combination, and to regulate the occurrence ofcis-and transreactions at the same time. It should be of interest to see if such a mechanism(s) is confined in the immune system .
In so much as trans-splicing takes place in transgenic B cells stimulated with LPS and IL4, it is reasonable to assume that the trans-splicing accounts for the Ig multiple isotype expression in B cells (12) (13) (14) (15) . This trans-splicing model is consistent with observations that the germline transcripts from specific C genes are expressed in association with class switching (16-19) and that Fl rabbits express significant levels of V and CH allotypic markers with trans-combination on membrane-bound and secreted Ig molecules (58) (59) (60) .
Until now, the immunological significance of the cells that express multiple Ig isotypes has not been well established. One interesting possibility is that they might be intermediates for the class switching (2) . Our data shown here would support this possibility because the second expressed isotype by trans-splicing should correlate with the isotype of the germline transcripts and thus target specificity of S-S recombination. One of the most attractive yet speculative possibilities is that the second Ig isotype molecules expressed on the cell surface might produce a positive or negative feedback signal for S-S recombination by themselves or through the recognition and production of mediators by other type of cells. Thus, the B cell might be able to express the most suitable isotype
